Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01539993 · ClinicalTrials.gov registry record

Prospective Liver Study

A clinical trial, sponsored by Emory University.

Completed
Registry status
400
Enrollment target

NCT01539993: Completed study, sponsored by Emory University.

NCT01539993 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01539993 has completed, sponsored by Emory University.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

Primary Outcome

QOL questionnaire will be collected during follow up visit.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2008-11
Est. Completion 2014-01
Emory University

1,208 total trials

What the finished NCT01539993 record still lists

NCT01539993 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01539993 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01539993 about?

NCT01539993 is a clinical study titled "Prospective Liver Study". This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

What is the current status of trial NCT01539993?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2008-11. Estimated completion is 2014-01.

Who is sponsoring clinical trial NCT01539993?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01539993, the US trial registry maintained by the National Library of Medicine. NCT01539993 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.